163 related articles for article (PubMed ID: 14569206)
1. Fibroblast and endothelial apoptosis in systemic sclerosis.
Jun JB; Kuechle M; Harlan JM; Elkon KB
Curr Opin Rheumatol; 2003 Nov; 15(6):756-60. PubMed ID: 14569206
[TBL] [Abstract][Full Text] [Related]
2. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis.
Jelaska A; Korn JH
Arthritis Rheum; 2000 Oct; 43(10):2230-9. PubMed ID: 11037882
[TBL] [Abstract][Full Text] [Related]
3. Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis.
Laplante P; Raymond MA; Gagnon G; Vigneault N; Sasseville AM; Langelier Y; Bernard M; Raymond Y; Hébert MJ
J Immunol; 2005 May; 174(9):5740-9. PubMed ID: 15843576
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in fibroblast signaling and biology in scleroderma.
Pannu J; Trojanowska M
Curr Opin Rheumatol; 2004 Nov; 16(6):739-45. PubMed ID: 15577613
[TBL] [Abstract][Full Text] [Related]
5. [Systemic sclerosis: pathophysiology of a multifaceted disease].
Servettaz A; Agard C; Tamby MC; Guilpain P; Guillevin L; Mouthon L
Presse Med; 2006 Dec; 35(12 Pt 2):1903-15. PubMed ID: 17159716
[TBL] [Abstract][Full Text] [Related]
6. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis.
Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411
[TBL] [Abstract][Full Text] [Related]
7. Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts.
Santiago B; Galindo M; Rivero M; Pablos JL
Arthritis Rheum; 2001 Jul; 44(7):1667-76. PubMed ID: 11465719
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis.
Maurer B; Busch N; Jüngel A; Pileckyte M; Gay RE; Michel BA; Schett G; Gay S; Distler J; Distler O
Circulation; 2009 Dec; 120(23):2367-76. PubMed ID: 19933934
[TBL] [Abstract][Full Text] [Related]
9. The role of vascular endothelium in fibroblast activation and tissue fibrosis, particularly in scleroderma (systemic sclerosis) and pachydermoperiostosis (primary hypertrophic osteoarthropathy).
Kahaleh MB
Clin Exp Rheumatol; 1992; 10 Suppl 7():51-6. PubMed ID: 1623675
[TBL] [Abstract][Full Text] [Related]
10. Cytokines and human fibrosis.
LeRoy EC; Trojanowska MI; Smith EA
Eur Cytokine Netw; 1990; 1(4):215-9. PubMed ID: 1966552
[TBL] [Abstract][Full Text] [Related]
11. Scleroderma fibroblasts demonstrate enhanced activation of Akt (protein kinase B) in situ.
Jun JB; Kuechle M; Min J; Shim SC; Kim G; Montenegro V; Korn JH; Elkon KB
J Invest Dermatol; 2005 Feb; 124(2):298-303. PubMed ID: 15675946
[TBL] [Abstract][Full Text] [Related]
12. Endothelial injury in internal organs of University of California at Davis line 200 (UCD 200) chickens, an animal model for systemic sclerosis (Scleroderma).
Nguyen VA; Sgonc R; Dietrich H; Wick G
J Autoimmun; 2000 Mar; 14(2):143-9. PubMed ID: 10677245
[TBL] [Abstract][Full Text] [Related]
13. Progress in research into systemic sclerosis.
Kahaleh B
Lancet; 2004 Aug 14-20; 364(9434):561-2. PubMed ID: 15313340
[No Abstract] [Full Text] [Related]
14. Macro- and microvascular disease in systemic sclerosis.
Kavian N; Batteux F
Vascul Pharmacol; 2015 Aug; 71():16-23. PubMed ID: 26044180
[TBL] [Abstract][Full Text] [Related]
15. Update on pathophysiology of scleroderma with special reference to immunoinflammatory events.
Chizzolini C
Ann Med; 2007; 39(1):42-53. PubMed ID: 17364450
[TBL] [Abstract][Full Text] [Related]
16. The vascular perspective of systemic sclerosis: of chickens, mice and men.
Sgonc R
Int Arch Allergy Immunol; 1999 Nov; 120(3):169-76. PubMed ID: 10592461
[TBL] [Abstract][Full Text] [Related]
17. Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis.
Postlethwaite AE; Shigemitsu H; Kanangat S
Curr Opin Rheumatol; 2004 Nov; 16(6):733-8. PubMed ID: 15577612
[TBL] [Abstract][Full Text] [Related]
18. Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.
Corallo C; Cutolo M; Kahaleh B; Pecetti G; Montella A; Chirico C; Soldano S; Nuti R; Giordano N
Arthritis Res Ther; 2016 Oct; 18(1):228. PubMed ID: 27716320
[TBL] [Abstract][Full Text] [Related]
19. Scleroderma fibroblasts show increased responsiveness to endothelial cell-derived IL-1 and bFGF.
Denton CP; Xu S; Black CM; Pearson JD
J Invest Dermatol; 1997 Mar; 108(3):269-74. PubMed ID: 9036923
[TBL] [Abstract][Full Text] [Related]
20. Autoimmunity and vascular involvement in systemic sclerosis (SSc).
Kahaleh MB; LeRoy EC
Autoimmunity; 1999; 31(3):195-214. PubMed ID: 10739336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
